TEL: +86 571 56623320    EMAIL: [email protected]

Activated Pkcalpha/Erk1/2 Signaling Inhibits Tamoxifen-Induced Apoptosis in C6 Cells
SUNLONG BIOTECH / 2024-01-09
  • Author:Tian, F., Wu, H., Li, Z., Wang, N., Huang, J., Li, C. & Xie, F.

  • Periodical:Cancer investigation 27, 802-808 (2009)

  • Article source

Data have shown that tamoxifen (TAM) can be used to treat not only breast cancer with positive estrogen receptor (ER), but also negative ER including human glioma. However, the molecular mechanism of this drug against different kinds of cancers remains to be elucidated. In this study, we provided the evidence that PKCalpha-ERK1/2 signaling pathway plays a negative role in TAM-induced C6 cell apoptosis, and a combined utilization of TAM with inhibitors of PKCalpha or ERK1/2 could enhance the effectiveness of TAM on inhibiting tumor growth.

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha

Call us

+86 571 56623320

Address

Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China

Join Us with

Leave a message
* To protect against spam, please pass the CAPTCHA test below.